Browsing by Author Crea, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2010Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.McNeil, Catriona; O'Toole, Sandra; Crea, Paul; Lopez-Knowles, Elena; Millar, E.; Musgrove, Elizabeth A.; Sutherland, Robert L.; Zardawi, Sarah J; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyCytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients., Cancer Epidemiology, Biomarkers & Prevention, vol.19, 1,pp 301-309
2010Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusMcNeil, Catriona; O'Toole, Sandra; Biankin, Andrew V.; Crea, Paul; et al, various; Fox, Stephen B.; Lee, Cheok; Millar, E.; Murphy, Niamh; Olayioye, Monilola; Segara, Davendra; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyLoss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status, International Journal of Cancer, vol.126, 6,pp 1445-1453
2010PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortalityO'Toole, Sandra; Crea, Paul; Daly, Roger; Lopez-Knowles, Elena; McNeil, Catriona; Millar, E.; Musgrove, Elizabeth A.; Qiu, Min Ru; Sutherland, Robert L.; Central Clinical School: PathologyPI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality, International Journal of Cancer, vol.126, 5,pp 1121-1131